Dogwood Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Dogwood Therapeutics, Inc. (DWTX) reported Basic Shares Outstanding (Weighted Average) of 34.13 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 34.13M shares, a 1685.83% increase year-over-year.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 33.54M shares, a 2227.02% increase year-over-year.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 14.63M shares, a 1014.34% increase year-over-year.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.92M shares, a 72.87% increase year-over-year.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 4.98M shares, a 384.29% increase from fiscal 2024.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.03M shares, a 36.84% increase from fiscal 2023.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 751.07K shares, a 93.22% decline from fiscal 2022.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 11.07M shares, a 32.91% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 34.13M shares 10-Q · filed 2026-08-14 | 33.84M shares 10-Q · filed 2026-08-14 | 27.43M shares derived: average of 3 quarters · filed 2026-08-14 | 21.05M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 33.54M shares 10-Q · filed 2026-05-15 | 24.09M shares derived: average of 2 quarters · filed 2026-05-15 | 16.70M shares derived: average of 3 quarters · filed 2026-05-15 | 13.00M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 14.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 8.27M shares derived: average of 2 quarters · filed 2026-03-18 | 6.15M shares derived: average of 3 quarters · filed 2026-08-14 | 4.98M shares 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | 1.92M shares 10-Q · filed 2025-11-07 | 1.92M shares derived: average of 2 quarters · filed 2026-08-14 | 1.76M shares 10-Q · filed 2025-11-07 | 1.65M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 1.91M shares 10-Q · filed 2026-08-14 | 1.68M shares 10-Q · filed 2026-08-14 | 1.56M shares derived: average of 3 quarters · filed 2026-08-14 | 1.44M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 1.44M shares 10-Q · filed 2026-05-15 | 1.38M shares derived: average of 2 quarters · filed 2026-05-15 | 1.29M shares derived: average of 3 quarters · filed 2026-05-15 | 1.20M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 1.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 1.21M shares derived: average of 2 quarters · filed 2026-03-18 | 1.11M shares derived: average of 3 quarters · filed 2026-03-18 | 1.03M shares 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | 1.11M shares 10-Q · filed 2025-11-07 | 1.01M shares derived: average of 2 quarters · filed 2025-11-07 | 932.87K shares 10-Q · filed 2025-11-07 | 891.80K shares derived: average of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | 916.03K shares 10-Q · filed 2025-08-13 | 22.90M shares 10-Q · filed 2024-08-09 | 843.17K shares 10-Q · filed 2025-08-13 | 21.08M shares 10-Q · filed 2024-08-09 | 818.96K shares derived: average of 3 quarters · filed 2025-08-13 | 805.16K shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 770.32K shares 10-Q · filed 2025-05-09 | 19.26M shares 10-Q · filed 2024-05-10 | 770.42K shares derived: average of 2 quarters · filed 2025-05-09 | 768.20K shares derived: average of 3 quarters · filed 2025-05-09 | 5.18M shares derived: average of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | 770.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 767.14K shares derived: average of 2 quarters · filed 2025-03-31 | 6.65M shares derived: average of 3 quarters · filed 2025-03-31 | 751.07K shares 10-K · filed 2025-03-31 | 18.78M shares 10-K · filed 2024-03-01 | |||
| 2023-09-30 | 763.75K shares 10-Q · filed 2024-11-08 | 19.09M shares 10-Q · filed 2023-11-13 | 9.59M shares derived: average of 2 quarters · filed 2024-11-08 | 744.59K shares 10-Q · filed 2024-11-08 | 18.61M shares 10-Q · filed 2023-11-13 | 13.98M shares derived: average of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | 18.41M shares 10-Q · filed 2024-08-09 | 18.37M shares 10-Q · filed 2024-08-09 | 18.38M shares derived: average of 3 quarters · filed 2024-08-09 | 16.09M shares derived: average of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | 18.33M shares 10-Q · filed 2024-05-10 | 18.37M shares derived: average of 2 quarters · filed 2024-05-10 | 15.31M shares derived: average of 3 quarters · filed 2024-05-10 | 13.57M shares derived: average of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | 18.41M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-08 | 13.81M shares derived: average of 2 quarters · filed 2024-03-08 | 11.98M shares derived: average of 3 quarters · filed 2024-03-08 | 11.07M shares 10-K/A · filed 2024-03-08 | ||||
| 2022-09-30 | 9.20M shares 10-Q · filed 2023-11-13 | 8.77M shares derived: average of 2 quarters · filed 2023-11-13 | 8.62M shares 10-Q · filed 2023-11-13 | 8.55M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 8.33M shares 10-Q · filed 2023-08-11 | 8.33M shares 10-Q · filed 2023-08-11 | 8.33M shares derived: average of 3 quarters · filed 2023-08-11 | 8.33M shares derived: average of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | 8.33M shares 10-Q · filed 2023-05-12 | 8.33M shares derived: average of 2 quarters · filed 2023-05-12 | 8.33M shares derived: average of 3 quarters · filed 2023-05-12 | 8.33M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 8.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 8.33M shares derived: average of 2 quarters · filed 2023-03-14 | 8.33M shares derived: average of 3 quarters · filed 2023-03-14 | 8.33M shares 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | 8.33M shares 10-Q · filed 2022-11-14 | 8.33M shares derived: average of 2 quarters · filed 2022-11-14 | 8.33M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 8.33M shares 10-Q · filed 2022-08-12 | 8.33M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 8.33M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 4.93M shares 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |